+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-infectives Market by Product Type, Indication, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Anti-infectives Market by Product Type, Indication, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Anti-infectives Market by Product Type, Indication, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015081
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global anti-infectives market is navigating a period of rapid transformation, with industry participants responding to escalating antimicrobial resistance, shifting regulatory landscapes, and breakthrough technologies. Senior decision-makers require authoritative, actionable insights to inform strategy in a field where innovation, access, and stewardship are all critical for long-term success.

Market Snapshot: Anti-infectives Market Overview

The Anti-infectives Market grew from USD 131.43 billion in 2024 to USD 138.37 billion in 2025 and is projected to reach USD 178.52 billion by 2030, registering a CAGR of 5.23%. This robust growth reflects heightened demand for advanced anti-infective therapies, combined with ongoing policy and technological advancements shaping the field.

Scope & Segmentation

This comprehensive research report delivers in-depth analysis and forecasts on key market dimensions. Segments covered include:

  • Product Types: Antibiotics (Aminoglycosides, Beta Lactams, Fluoroquinolones, Macrolides, Sulfonamides, Tetracyclines); Antifungals (Allylamines, Azoles, Echinocandins, Polyenes); Antiparasitics (Anthelmintics, Antimalarials, Antiprotozoals); Antivirals (Neuraminidase Inhibitors, Nucleoside Analogues, Polymerase Inhibitors, Protease Inhibitors).
  • Indications: Bloodstream Infections, Gastrointestinal Infections, Respiratory Infections (Bronchitis, Community Acquired Pneumonia, Hospital Acquired Pneumonia), Skin and Soft Tissue Infections, Urinary Tract Infections.
  • Routes of Administration: Inhalation, Oral, Parenteral, Topical.
  • Distribution Channels: Drug Stores, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies.
  • End Users: Clinics, Home Care Settings, Hospitals.
  • Regions: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Roche Holding AG, Johnson & Johnson, Sanofi S.A., AstraZeneca plc, Novartis AG, Bayer Aktiengesellschaft, Astellas Pharma Inc.

Key Takeaways

  • AI-driven drug design and digital surveillance are accelerating new anti-infective development, leading to more targeted therapies and shorter development timelines.
  • Cross-sector collaboration, including public-private partnerships and academic consortia, is strengthening clinical research and advancing stewardship programs across markets.
  • Patient-centric approaches, such as home-based care and value-based contracting, are reshaping access models, impacting how therapies are priced, distributed, and reimbursed.
  • Regional dynamics are highly nuanced: the Americas excel in R&D investment, EMEA focuses on regulatory harmonization, and Asia-Pacific is experiencing growth driven by expanded access and manufacturing investments.
  • Companies are pursuing diversified manufacturing, supply chain resilience, and digital health integration to manage competitive pressure and regulatory complexity.

Tariff Impact on the Anti-infectives Market

The introduction of US tariffs on pharmaceutical imports in 2025 has materially affected the anti-infectives supply chain. Manufacturers have revisited sourcing strategies, increasingly considering nearshoring and varied manufacturing partnerships to safeguard supply continuity and manage cost volatility. Procurement and regulatory teams are recalibrating processes to adapt to new customs requirements and evolving trade dynamics.

Methodology & Data Sources

This report is underpinned by rigorous secondary research, supplemented with targeted primary expert interviews. Data triangulation from peer-reviewed publications, regulatory filings, industry disclosures, and regional market intelligence ensures accuracy. All findings were subject to internal industry specialist review for relevance and completeness.

Why This Report Matters

  • Enables executives in pharma, biotech, and healthcare delivery to anticipate market disruptions and capitalize on emerging opportunities across geographies.
  • Equips decision-makers with practical strategies for managing supply chain vulnerabilities and evolving reimbursement frameworks.
  • Delivers differentiated competitive intelligence, supporting evidence-based planning for R&D, commercial strategy, and risk mitigation.

Conclusion

As anti-infective innovation, regulatory forces, and commercial models evolve, this report provides the clarity leaders need to adapt, collaborate, and sustain growth. Informed decision-making now will help ensure timely patient access and continued competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anti-infectives Market, by Product Type
8.1. Introduction
8.2. Antibiotics
8.2.1. Aminoglycosides
8.2.2. Beta Lactams
8.2.3. Fluoroquinolones
8.2.4. Macrolides
8.2.5. Sulfonamides
8.2.6. Tetracyclines
8.3. Antifungals
8.3.1. Allylamines
8.3.2. Azoles
8.3.3. Echinocandins
8.3.4. Polyenes
8.4. Antiparasitics
8.4.1. Anthelmintics
8.4.2. Antimalarials
8.4.3. Antiprotozoals
8.5. Antivirals
8.5.1. Neuraminidase Inhibitors
8.5.2. Nucleoside Analogues
8.5.3. Polymerase Inhibitors
8.5.4. Protease Inhibitors
9. Anti-infectives Market, by Indication
9.1. Introduction
9.2. Bloodstream Infections
9.3. Gastrointestinal Infections
9.4. Respiratory Infections
9.4.1. Bronchitis
9.4.2. Community Acquired Pneumonia
9.4.3. Hospital Acquired Pneumonia
9.5. Skin And Soft Tissue Infections
9.6. Urinary Tract Infections
10. Anti-infectives Market, by Route Of Administration
10.1. Introduction
10.2. Inhalation
10.3. Oral
10.4. Parenteral
10.5. Topical
11. Anti-infectives Market, by Distribution Channel
11.1. Introduction
11.2. Drug Stores
11.3. Hospital Pharmacies
11.4. Online Pharmacies
11.5. Retail Pharmacies
12. Anti-infectives Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Care Settings
12.4. Hospitals
13. Americas Anti-infectives Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Anti-infectives Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Anti-infectives Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Merck & Co., Inc.
16.3.3. GlaxoSmithKline plc
16.3.4. Roche Holding AG
16.3.5. Johnson & Johnson
16.3.6. Sanofi S.A.
16.3.7. AstraZeneca plc
16.3.8. Novartis AG
16.3.9. Bayer Aktiengesellschaft
16.3.10. Astellas Pharma Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTI-INFECTIVES MARKET MULTI-CURRENCY
FIGURE 2. ANTI-INFECTIVES MARKET MULTI-LANGUAGE
FIGURE 3. ANTI-INFECTIVES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTI-INFECTIVES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ALLYLAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYENES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIMALARIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NUCLEOSIDE ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYMERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. CANADA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 80. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 81. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 82. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 83. CANADA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. CANADA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 85. CANADA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. CANADA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. CANADA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. MEXICO ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. MEXICO ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. MEXICO ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. GERMANY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 141. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 142. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 143. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 144. GERMANY ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. GERMANY ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 146. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. GERMANY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. FRANCE ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 154. FRANCE ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. FRANCE ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 156. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. FRANCE ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. FRANCE ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. ITALY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 171. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 172. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 173. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 174. ITALY ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. ITALY ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 176. ITALY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. ITALY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. ITALY ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SPAIN ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SPAIN ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 181. SPAIN ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 182. SPAIN ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 183. SPAIN ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 184. SPAIN ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. SPAIN ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 186. SPAIN ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. SPAIN ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. SPAIN ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. DENMARK ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. DENMARK ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 221. DENMARK ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 222. DENMARK ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 223. DENMARK ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 224. DENMARK ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 225. DENMARK ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 226. DENMARK ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. DENMARK ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. DENMARK ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. QATAR ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. QATAR ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 241. QATAR ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 242. QATAR ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 243. QATAR ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 244. QATAR ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 245. QATAR ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 246. QATAR ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. QATAR ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. QATAR ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. FINLAND ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. FINLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 251. FINLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 252. FINLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 253. FINLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 254. FINLAND ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 255. FINLAND ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 256. FINLAND ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. FINLAND ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. FINLAND ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 263. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 264. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 265. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 266. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. EGYPT ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. EGYPT ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 281. EGYPT ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 282. EGYPT ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 283. EGYPT ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 284. EGYPT ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 285. EGYPT ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 286. EGYPT ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. EGYPT ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. EGYPT ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. TURKEY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. TURKEY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 291. TURKEY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 292. TURKEY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 293. TURKEY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 294. TURKEY ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 295. TURKEY ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 296. TURKEY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. TURKEY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. TURKEY ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 306. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 307. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. ISRAEL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. NORWAY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. NORWAY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 311. NORWAY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 312. NORWAY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 313. NORWAY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 314. NORWAY ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 315. NORWAY ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 316. NORWAY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 317. NORWAY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. NORWAY ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. POLAND ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. POLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 321. POLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 322. POLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 323. POLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 324. POLAND ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 325. POLAND ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 326. POLAND ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. POLAND ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. POLAND ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 330. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 331. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 332. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 333. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 334. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 335. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 336. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 337. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 338. SWITZERLAND ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 340. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 342. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2030 (USD MILLION)
TABLE 344. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 345. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2030 (USD MILLION)
TABLE 346. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 347. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 348. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 349. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 350. CHINA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 351. CHINA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 352. CHINA ANTI-INFE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Anti-infectives market report include:
  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • AstraZeneca plc
  • Novartis AG
  • Bayer Aktiengesellschaft
  • Astellas Pharma Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 138.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 178.52 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Anti-Infective Drugs- Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Anti-Infective Drugs- Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2025-2033 - Product Image

Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2025-2033

  • Report
  • 136 Pages
  • Global
From
Anti-Infectives - Global Strategic Business Report - Product Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • 116 Pages
  • Global
From
Anti-infective Endotracheal Tube Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Anti-infective Endotracheal Tube Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From

About the Infection Drug Market

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.